경장영양 튜브 시장, 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

The Global Enteral Feeding Tubes Market will witness a 6.3% from 2024 to 2032, driven by advancements in enteral feeding technology, a rising prevalence of chronic diseases, an aging population, an uptick in preterm births, and a growing trend towards home healthcare adoption, among other factors.

Factors driving the growth of the enteral feeding tubes industry include technological advancements, an aging population, and a rise in chronic diseases. As healthcare technology evolves, enteral feeding methods become more efficient and user-friendly, leading to increased adoption. The global rise in chronic diseases, especially in aging populations, necessitates nutritional support, further propelling market growth. Additionally, the surge in preterm births and the growing trend of home healthcare adoption underscore the expanding demand for enteral feeding solutions.

The Enteral Feeding Tubes Market is categorized based on product, disease condition, patient, tube type, tube placement, end use , and region.

The market categorizes products into nasoenteric/nasal feeding tubes and abdominal/ostomy feeding tubes. The nasoenteric/nasal feeding tube segment includes nasogastric and nasojejunal tubes, while the abdominal/ostomy segment encompasses gastrostomy, jejunostomy/jejunal, and gastrojejunal (GJ) or transjejunal tubes. The nasoenteric/nasal feeding tube segment led the market with a revenue of USD 1.7 billion in 2023. Nasoenteric tubes, favored for short-term feeding (typically under four weeks), are less invasive than other methods. This makes them ideal for temporary nutritional support across various clinical scenarios. Moreover, patients in intensive care units (ICUs), often unable to eat orally, increasingly rely on nasoenteric feeding tubes. This trend, driven by rising ICU admissions from critical illnesses and surgeries, underscores the segment's growth.

The market classifies enteral feeding tubes based on disease conditions, including cancer, central nervous system (CNS) & mental health issues, non-malignant gastrointestinal (GI) disorders, and others. The cancer segment, further divided into head and neck, gastrointestinal, and other cancers, commanded a 48% enteral feeding tubes market share in 2023. Treatments like chemotherapy and radiation can induce side effects such as nausea and difficulty swallowing. With advancements in cancer treatments boosting survival rates, the demand for long-term nutritional support has surged, propelling the segment's growth.

North America enteral feeding tubes market accounted for USD 876.2 million in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2032. As a frontrunner in healthcare innovation, North America has been pivotal in advancing enteral feeding technologies. Innovations, including enhanced feeding tube designs and efficient feeding pumps, have spurred adoption rates. Additionally, pediatric patients, often facing congenital abnormalities and severe illnesses, have a heightened need for enteral feeding. This specialized nutritional demand for vulnerable pediatric populations has further fueled the regional market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in number of cancer cases across the globe
    • 3.2.1.2 Rise in incidence of premature births and pediatric diseases
    • 3.2.1.3 Growing central nervous system and mental health disorders
    • 3.2.1.4 Increasing metabolic disorders
    • 3.2.1.5 Recent technological advancements
    • 3.2.1.6 Rise in adoption of home healthcare
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of awareness in developing and under-developed regions
    • 3.2.2.2 Risks associated with enteral feeding
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Gap analysis
• 3.6 Technology landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Nasoenteric/nasal feeding tube
  • 5.2.1 Nasogastric tube
  • 5.2.2 Nasojejunal tube
• 5.3 Abdominal/ostomy feeding tube
  • 5.3.1 Gastrostomy tube
  • 5.3.2 Jejunostomy/jejunal tube
  • 5.3.3 Gastrojejunal (GJ) or transjejunal tube

Chapter 6 Market Estimates and Forecast, By Disease Condition, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Cancer
  • 6.2.1 Head and neck cancer
  • 6.2.2 Gastrointestinal cancer
  • 6.2.3 Other cancers
• 6.3 Central nervous system (CNS) and mental health
• 6.4 Non-malignant gastrointestinal (GI) disorders
• 6.5 Other disease conditions

Chapter 7 Market Estimates and Forecast, By Patient, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By Tube Type, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Short term feeding tube
• 8.3 Long term feeding tube
• 8.4 Temporary feeding tube

Chapter 9 Market Estimates and Forecast, By Tube Placement, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Without surgery
• 9.3 Surgical placement
• 9.4 Endoscopic placement

Chapter 10 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 Home care
• 10.3 Hospitals
• 10.4 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Spain
  • 11.3.5 Italy
  • 11.3.6 Netherlands
  • 11.3.7 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 Japan
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 South Korea
  • 11.4.6 Rest of Asia Pacific
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
  • 11.5.4 Rest of Latin America
• 11.6 Middle East and Africa
  • 11.6.1 South Africa
  • 11.6.2 Saudi Arabia
  • 11.6.3 UAE
  • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

• 12.1 Abbott Laboratories
• 12.2 Applied Medical Technology, Inc.
• 12.3 Avanos Medical, Inc.
• 12.4 B. Braun Melsungen AG
• 12.5 Becton, Dickinson and Company
• 12.6 Boston Scientific Corporation
• 12.7 C.R. Bard, Inc.
• 12.8 Cardinal Health
• 12.9 CONMED Corporation
• 12.10 Cook Medical
• 12.11 Danone S.A.
• 12.12 Fresenius Kabi AG
• 12.13 Medline Industries, Inc.
• 12.14 MOOG Inc.
• 12.15 Vygon